Sandeep Kumar

Dr. Sandeep Kumar

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2024 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
VSVikas Sharma
Vikas Sharma
ACAnis Ahmad Chaudhary
Anis Ahmad Chaudhary
SBSweta Bawari
Sweta Bawari
SGSaurabh Gupta
Saurabh Gupta
RMRicha Mishra
Richa Mishra
SKSandeep Kumar
Sandeep Kumar
Cancer prevention is currently envisioned as a molecular-based approach to prevent carcinogenesis in pre-cancerous stages, i.e., dysplasia and carcinoma in situ. Cancer is the second-leading cause of mortality worldwide, and a more than 61% increase is expected by 2040. A detailed exploration of cancer progression pathways, including the NF-kβ signaling pathway, Wnt-B catenin signaling pathway, JAK-STAT pathway, TNF-α-mediated pathway, MAPK/mTOR pathway, and apoptotic and angiogenic pathways and effector molecules involved in cancer development, has been discussed in the manuscript. Critical evaluation of these effector molecules through molecular approaches using phytomolecules can intersect cancer formation and its metastasis. Manipulation of effector molecules like NF-kβ, SOCS, β-catenin, BAX, BAK, VEGF, STAT, Bcl2, p53, caspases, and CDKs has played an important role in inhibiting tumor growth and its spread. Plant-derived secondary metabolites obtained from natural sources have been extensively studied for their cancer-preventing potential in the last few decades. Eugenol, anethole, capsaicin, sanguinarine, EGCG, 6-gingerol, and resveratrol are some examples of such interesting lead molecules and are mentioned in the manuscript. This work is an attempt to put forward a comprehensive approach to understanding cancer progression pathways and their management using effector herbal molecules. The role of different plant metabolites and their chronic toxicity profiling in modulating cancer development pathways has also been highlighted.

18 December 2023 in Drug Discovery Today
Verified
Journal Article
Closed access
HFHaleema Fayaz
Haleema Fayaz
TGTanishka Gupta
Tanishka Gupta
SRSafia Obaidur Rab
Safia Obaidur Rab
SJSaurabh Kumar Jha
Saurabh Kumar Jha
SKSandeep Kumar
Sandeep Kumar

13 October 2022 in Catalysts
Verified
Journal Article
Open access
PDF file
NANada Alfryyan
Nada Alfryyan
SKSandeep Kumar
Sandeep Kumar
SASamia Ben Ahmed
Samia Ben Ahmed
IKImen Kebaili
Imen Kebaili
IBImed boukhris
Imed boukhris
RVRahul Vaish
Rahul Vaish
BaTiO3-polymer paint composites were fabricated to examine piezocatalysis activities. Dye degradation and antibacterial activities were recorded under ultrasonication. The effect of polarization was also examined for the catalysis process. There were significant enhancements in catalysis performance in the poled sample; 80–90% dye degradation was recorded (240 min) in poled samples of BaTiO3-polymer paint composites. The above observations indicate that these composites can be utilized as coatings for self-cleaning applications.

23 February 2026 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
Chou Yi HsuChou Yi Hsu
Chou Yi Hsu
YAYasir Qasim Almajidi
Yasir Qasim Almajidi
MAMohammad Abohassan
Mohammad Abohassan
RGRushen Gafarov
Rushen Gafarov
TBTina Saeed Basunduwah
Tina Saeed Basunduwah
KJKarthikeyan Jayabalan
Karthikeyan Jayabalan

25 February 2025 in In Silico Pharmacology
Verified
Journal Article
Closed access
PDF file
VSVikas Sharma
Vikas Sharma
AGArti Gupta
Arti Gupta
ASAnshul Singh
Anshul Singh
STShivani Tyagi
Shivani Tyagi
HPHrithika Panday
Hrithika Panday
SKSandeep Kumar
Sandeep Kumar

19 February 2025 in Frontiers in Bioinformatics
Verified
Journal Article
Open access
PDF file
VSVikas Sharma
Vikas Sharma
AGArti Gupta
Arti Gupta
MSMohini Singh
Mohini Singh
ASAnshul Singh
Anshul Singh
ACAnis Ahmad Chaudhary
Anis Ahmad Chaudhary
SKSandeep Kumar
Sandeep Kumar
Background: The rising prevalence of cancer cells exhibits uncontrolled growth and invasive and aggressive properties, leading to metastasis, which poses a significant challenge for global health. Central to cancer development are proteins such as NF-kB, p53, VEGF, and BAX/Bcl-2, which play important roles in angiogenesis, cell apoptosis regulation, and tumor growth.Methodology: This in silico study evaluates the activity of six different natural as well as novel therapeutic strategies against cancer. Using a computational approach, i.e., virtual screening, molecular docking, and molecular dynamics (MD) simulations, the binding affinities and interactions of selected phytochemicals with cancer-specific proteins were analyzed. Key criteria for selection included binding affinity, molecular stability, and pharmacokinetic and toxicological properties. Post-selection, dynamics of ligand–protein interactions were further examined through MD simulations conducted using Desmond-Maestro 2020-4 on a Linux-based HP Z2 workstation, providing an insight into the conformational changes in the stability of the inhibitor–protein complexes. This was complemented by ADMET predictions to assess pharmacokinetics and toxicological profiles.Results: Our findings reveal that out of six phytochemicals, baicalin exhibited the most promising results, with docking scores of −9.2 kcal/mol and −9.0 kcal/mol against Bcl-2 and VEGF receptors, respectively. The MD simulation (100 ns) confirmed the stability of baicalin–protein interactions, supported by hydrophobic interactions and intermolecular hydrogen bonds. The RMSD and RMSF values of baicalin exhibit an acceptable global minimum (3.5–6 Å) for p53, VEGF, and BAX/Bcl-2.Conclusion: This study highlights the potential of baicalin, a phytochemical known for anti-cancerous, anti-apoptotic, and anti-proliferative properties, as a promising candidate for cancer treatment. Further exploration and validation of its inhibitory mechanisms could open a promising avenue for therapeutic approaches in oncology.